Okabe, Seiichi <br/><br/>
Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line.  [electronic resource] 

 -  Journal of hematology & oncology  Aug 2011 
 - 32 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/1756-8722-4-32  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Dasatinib<br/>Drug Resistance, Neoplasm<br/>Humans<br/>K562 Cells<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrimidines--pharmacology<br/>Thiazoles--pharmacology<br/>src-Family Kinases--antagonists & inhibitors